B. Access Immunoassay System - Br Monitor (Ca 15-3) Assay
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
387620
All non-expired lots and future lots
C. Unicel Dxi 800 Access Immunoassay System - Br Monitor (Ca 15-3) Assay
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
387620
All non-expired lots and future lots
A. Unicel Dxi 600 Access Immunoassay System - Br Monitor (Ca 15-3) Assay
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
387620
Introduction
Affected Products
A. Unicel Dxi 600 Access Immunoassay System - Br Monitor (Ca 15-3) Assay
B. Access Immunoassay System - Br Monitor (Ca 15-3) Assay
C. Unicel Dxi 800 Access Immunoassay System - Br Monitor (Ca 15-3) Assay
Reason
Following biases observed in the results of the French national quality controls, Beckman Coulter has been informed that a study completed by the French competent authority Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM) showed diagnosed cancer patients in non-remission of their metastatic disease, may have results below the upper reference limit (URL) of 31.3 u/ml as stated in the access BR monitor instructions for use (IFU).